Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximabNicholas A Kennedy, James R Goodhand, Claire Bewshea, Rachel Nice, Desmond Chee, Simeng Lin, Neil Chanchlani, Jeffrey Butterworth, Rachel Cooney, Nicholas M Croft, Ailsa L Hart, Peter M Irving, Klaartje B Kok, Christopher A Lamb, Jimmy K LimdiSee the full list of authors
22 March 2021
Multicentre prospective study of COVID-19 transmission following outpatient GI endoscopy in the UKBu'Hussain Hayee, The SCOTS project group, James East, Colin J Rees, Ian Penman, The SCOTS project group, Amyn Haji, Shraddha Gulati, Joel Mawdsley, Freya Parker, Ed Seward, Melanie Corpus, Srisha Hebbar, Rajeev Desai, Nick KennedySee the full list of authors
14 September 2020
COVID-19 and IBD drugs: should we change anything at the moment?Charlie W Lees, Peter M Irving, Laurent Beaugerie
19 November 2020
Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19Terry Cheuk-Fung Yip, Grace Chung-Yan Lui, Vincent Wai-Sun Wong, Viola Chi-Ying Chow, Tracy Hang-Yee Ho, Timothy Chun-Man Li, Yee-Kit Tse, David Shu-Cheong Hui, Henry Lik-Yuen Chan, Grace Lai-Hung Wong
8 July 2020
SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meetingCorey A Siegel, Gil Y Melmed, Dermot PB McGovern, Victoria Rai, Florian Krammer, David T Rubin, Maria T Abreu, Marla C Dubinsky, , on behalf of the International Organization for the Study of Inflammatory Bowel Diseases (IOIBD), Vineet Ahuja, Matthieu Allez, Ashwin N Ananthakrishnan, Charles N Bernstein, Jonathan BraunSee the full list of authors
20 January 2021
Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19Yun Kit Yeoh, Tao Zuo, Grace Chung-Yan Lui, Fen Zhang, Qin Liu, Amy YL Li, Arthur CK Chung, Chun Pan Cheung, Eugene YK Tso, Kitty SC Fung, Veronica Chan, Lowell Ling, Gavin Joynt, David Shu-Cheong Hui, Kai Ming ChowSee the full list of authors
11 January 2021
Effect of IBD medications on COVID-19 outcomes: results from an international registryRyan C Ungaro, Erica J Brenner, Richard B Gearry, Gilaad G Kaplan, Michele Kissous-Hunt, James D Lewis, Siew C Ng, Jean-Francois Rahier, Walter Reinisch, Flávio Steinwurz, Fox E Underwood, Xian Zhang, Jean-Frederic Colombel, Michael D Kappelman
20 October 2020
Alteration of taste or smell as a predictor of COVID-19Jyh-Ming Liou, Mei-Jyh Chen, Tzu-Chan Hong, Ming-Shiang Wu
3 July 2020
Involvement of liver in COVID-19: systematic review and meta-analysisDipesh Kumar Yadav, Akanand Singh, Qi Zhang, Xueli Bai, Wei Zhang, Rajesh Kumar Yadav, Alina Singh, Li Zhiwei, Vishnu Prasad Adhikari, Tingbo Liang
15 July 2020
Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohortJasmohan S Bajaj, Guadalupe Garcia-Tsao, Scott W Biggins, Patrick S Kamath, Florence Wong, Sara McGeorge, Jawaid Shaw, Meredith Pearson, Micheal Chew, Andrew Fagan, Randolph de la Rosa Rodriguez, Janelle Worthington, Amy Olofson, Vanessa Weir, Calvin TrisoliniSee the full list of authors
13 July 2020
